Bone Void Fillers Market is estimated at $3.5 billion in 2022, is expected to grow at a CAGR of 6% by 2026

1
Bone Void Fillers Market is Expected to Gain
Popularity Across the Globe by 2026
2
A bone void is a cavity in bone that results from
a failure of the bone's self- healing process.
Infection, trauma, tumours, or orthopaedic
treatments can all cause healthy bone tissue to
be damaged or lost. A bone void filler/graft is a
material used to fill a bone defect or a void to
correct these conditions. Allografts, synthetic
grafts, and autografts can all be used to fill
bony voids. Global Bone Void Fillers Market is
estimated at 3.5 billion in 2022, is growing at
a CAGR of 6. Growing orthopaedic disorders and
technological developments are the main drivers
of market growth. Rising number of bone
fractures and people suffering from orthopaedic
disorders to drive the bone void fillers market
growth Orthopaedic disorders are becoming more
prevalent as the world's population ages. In the
U.S., 1.5 million people are diagnosed with
osteoporosis each year. Further, according to
International Osteoporosis Foundation, the number
of osteoporotic fractures in Europe (EU27,
Switzerland and the UK) would grow by 25 and
reach 5.3 million in 2034 from 4.3 million in
2019. The demand for bone void fillers would
increase as the number of fractures and the
orthopaedic population increased.
3
Advanced products such as antibiotics-based bone
void fillers to offer growth opportunities in
Bone Void Fillers Market Infection is main
problem after orthopaedic procedures and may lead
to serious consequences. As a result, major
players are concentrating on launching bone void
fillers developed in combination with
antibiotics. In June 2021, Elute, Inc. received
authorization from the US FDA to use its EP
Granules with Tobramycin in clinical trial. The
product is a resorbable bone void filler that
delivers a broad-spectrum antibiotic in a local
and targeted manner in the surgical treatment of
bone infections following hip or knee
replacements. Explore Premium Report on Bone
Void Fillers Market _at_ https//meditechinsights.com
/global-bone-void-fillers-market/ Regional
Overview North America leads the acceptance of
Bone Void Fillers Market Geographically speaking,
North America has a major market share of global
bone void fillers revenues. This is mostly
attributed to the huge number of orthopaedic
procedures, rising aging population, and
relatively higher penetration of bone void
filling products in the region.
4

• Companies adopting organic growth strategies to
  increase their market share
• As a main growth strategy, companies in the bone
  void fillers market are concentrating on
  launching new and advanced products to gain
  market share.
• For instance,
• In February 2022, Orthofix Medical launched a
  synthetic bioactive bone graft (Opus BA) for
  spine procedures.
• In January 2022, Bone Solutions Inc.
  (BSI) launched Mg OSTEOINJECT, an injectable
  Magnesium-based bone void filler.
• In September 2021, Orthofix Medical launched the
  Opus Mg Set osteoconductive scaffold, a synthetic
  magnesium-based bone void filler for orthopedic
  procedures. Opus Mg Set provides a
  procedure-specific solution for orthopedic
  fracture and trauma procedures by filling
  non-structural bony voids or gaps during surgery.
• Competitive Landscape Analysis Bone Void Fillers
  Market
• Some key players operating in the global bone
  void fillers market include Medtronic, Graftys,
  DePuy Synthes Companies (JnJ), Stryker, Baxter,
  bioventus, Orthofix, Bone Solutions Inc.,
  Curasan, Inc., Olympus Terumo Biomaterials
  Corporation, Biocomposites, Arthrex, Zimmer
  Biomet, Collagen Matrix, Bonesupport AB, among
  others.

5
For More Detailed Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com